Cargando…
Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
AIMS: 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB)3-mediated glycolysis is pivotal in driving macrophage- and endothelial cell activation and thereby inflammation. Once activated, these cells play a crucial role in the progression of atherosclerosis. Here, we analyzed the expression o...
Autores principales: | Poels, Kikkie, Schnitzler, Johan G., Waissi, Farahnaz, Levels, Johannes H. M., Stroes, Erik S. G., Daemen, Mat J. A. P., Lutgens, Esther, Pennekamp, Anne-Marije, De Kleijn, Dominique P. V., Seijkens, Tom T. P., Kroon, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688893/ https://www.ncbi.nlm.nih.gov/pubmed/33282864 http://dx.doi.org/10.3389/fcell.2020.581641 |
Ejemplares similares
-
E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020) -
Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022) -
Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
por: Poels, Kikkie, et al.
Publicado: (2020) -
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
por: Poels, Kikkie, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
por: Poels, Kikkie, et al.
Publicado: (2020)